TipRanks
Instadose Pharma (INSD)
OTHER OTC:INSD
US Market
INSD
Instadose Pharma
RESEARCH TOOLSreports

Instadose Pharma (INSD) Income Statement

18 Followers

Instadose Pharma Income Statement

Last quarter (Q1 2022), Instadose Pharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Instadose Pharma's net income was $-1.15M. See Instadose Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Nov 21Nov 20Nov 19Nov 18Nov 17
Total Revenue
$ 0.00$ 0.00$ 0.00-$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00-$ 0.00
Operating Expenses
$ 462.02K$ 25.66K$ 30.93K$ 25.31K$ 41.11K
Depreciation and Amortization
$ 361.59K$ 19.79K$ 0.00$ 0.00$ 0.00
EBITDA
$ -100.43K$ -5.87K$ -23.27K-$ -31.95K
Operating Income
$ -462.02K$ -25.66K$ -23.27K$ -23.54K$ -31.95K
Other Income/Expenses
$ 0.00$ 0.00$ 0.00--
Pretax Income
$ -462.02K$ -25.66K$ -23.27K--
Net Income
$ -589.00K$ -33.31K$ -38.58K--
Per Share Metrics
Basic EPS
$ >-0.01$ >-0.01$ >-0.01$ >-0.01$ >-0.01
Diluted EPS
$ >-0.01$ >-0.01$ >-0.01$ >-0.01$ >-0.01
Weighted Average Shares Outstanding
 75.00M 75.00M 75.00M 75.00M 75.00M
Weighted Average Shares Outstanding (Diluted)
 75.00M 75.00M 75.00M 75.00M 75.00M
Currency in USD

Instadose Pharma Earnings and Revenue History